LSE - Delayed Quote GBp
PureTech Health plc (PRTC.L)
130.00
+6.60
+(5.35%)
As of 3:52:34 PM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | 0 | 0 | -0.68 | -0.6 |
| Low Estimate | 0 | 0 | -0.68 | -0.6 |
| High Estimate | 0 | 0 | -0.68 | -0.6 |
| Year Ago EPS | -- | -- | -0.24 | -0.68 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 2 | 2 |
| Avg. Estimate | -- | -- | 15.25M | 14.25M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | 30.5M | 28.5M |
| Year Ago Sales | -- | -- | 3.33M | 15.25M |
| Sales Growth (year/est) | -- | -- | 357.96% | -6.56% |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -0.68 | -0.6 |
| 7 Days Ago | 0 | 0 | -0.7 | -0.62 |
| 30 Days Ago | 0 | 0 | -0.54 | -0.55 |
| 60 Days Ago | 0 | 0 | -0.54 | -0.55 |
| 90 Days Ago | 0 | 0 | -0.54 | -0.55 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | 1 | 1 |
| Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PRTC.L | -- | -- | -183.75% | 11.31% |
| S&P 500 | 7.01% | 4.85% | 8.55% | 14.15% |
Related Tickers
RYH0.F Sareum Holdings plc
0.1730
-3.35%
VT6.F Voyager Therapeutics, Inc.
2.7000
-0.74%
MAAT.PA MaaT Pharma SA
5.86
-2.98%
HVO.L hVIVO plc
16.38
+0.77%
OXB.L Oxford Biomedica plc
302.50
+1.17%
VOR Vor Biopharma Inc.
0.6750
-1.67%
KYMR Kymera Therapeutics, Inc.
28.44
+4.71%
SLN Silence Therapeutics plc
3.0900
-3.44%
CGON CG Oncology, Inc.
20.38
-0.15%
JANX Janux Therapeutics, Inc.
30.07
+2.63%